effects [qlco]
ADD [mobd]
Progestin [horm, phsu, strd]
Conjugated estrogen [horm, phsu, strd]
Moderately [qlco]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
Purpose [ftcn]
effects [qlco]
Fasting [fndg]
Plasma lipids [lbpr]
Lipoprotein [aapp, bacs]
ADD [mobd]
Dosage [qnco]
Continuous [idcn]
Progestin [horm, phsu, strd]
DL-Norgestrel [horm, phsu, strd]
Conventional [qlco]
Dosage [qnco]
Continuous [idcn]
Progestin [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
Cyclic [tmco]
Conjugated estrogen [horm, phsu, strd]
therapy [ftcn]
Study Design [resa]
Nine [qnco]
postmenopausal [tmco]
Women [popg]
Intact [qlco]
Uteri [bpoc]
Assigned [ftcn]
prospective [resa]
Double-Blind Study [resa]
cross over [genf]
Conjugated estrogen [horm, phsu, strd]
DL-Norgestrel [horm, phsu, strd]
mg day [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
2 5 [qnco]
mg day [qnco]
Appropriate [qlco]
Washout Period [tmco]
Switch [mnob]
Alternative [cnce]
Regimen [topp]
Subject [grup]
Received [qlco]
Conjugated estrogen [horm, phsu, strd]
Compared [acty]
baselines [bodm]
Progestin [horm, phsu, strd]
regimens [inpr]
Increased [qnco]
Plasma [bdsu]
High Density Lipoprotein Cholesterol [bacs, lipd]
Reduced [qlco]
Ratio [qnco]
Total Cholesterol [lbpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
Former [tmco]
Reduced [qlco]
Plasma [bdsu]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
Conclusions [idcn]
Dosages [qnco]
DL-Norgestrel [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
Combined [qlco]
Conjugated estrogen [horm, phsu, strd]
Plasma lipids [lbpr]
Lipoprotein [aapp, bacs]
postmenopausal [tmco]
Women [popg]
